About Index Trending news
Analyze
Pricing
Adimab, LLC

Adimab, LLC

Adimab, LLC

Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.

Elsewhere

Alexa global traffic share

03 Apr 2012
$14,000,000
Venture capital
22 Jan 2010
$8,200,000
Venture capital (Series D)
20 Nov 2008
$4,000,000
Venture capital (Series C)
21 Sep 2007
$5,900,000
Venture capital (Series A)